Lescol (fluvastatin sodium) capsules, Rx

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved June 1999

Specific Treatments:

Cardiology

Therapeutic Areas

General Information

Lescol has been approved as a treatment for the reduction of triglycerides and ApoB in patients with primary hypercholesterolemia and mixed dyslipidemia.